Literature DB >> 10397744

Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells.

M Sánchez-Beato1, F I Camacho, J C Martínez-Montero, A I Sáez, R Villuendas, L Sánchez-Verde, J F García, M A Piris.   

Abstract

p27 cyclin-dependent kinase inhibitor downregulation is essential for transition to the S phase of the cell cycle. Thus, proliferating cells in reactive lymphoid tissue show no detectable p27 expression. Nevertheless, anomalous high p27 expression has been shown to be present in a group of aggressive B-cell lymphomas with high proliferation index and adverse clinical outcome. This suggests that abnormally accumulated p27 protein has been rendered functionally inactive. We analyzed the causes of this anomalous presence of p27 in a group of aggressive B-cell lymphomas, including 54 cases of diffuse large B-cell lymphomas and 20 Burkitt's lymphomas. We simultaneously studied them for p27, cyclin D3, cyclin D2, cyclin D1, and cyclin E expression, because it has been stated that high levels of expression of cyclin D1 or E lead to increased p27 levels in some cell types. A statistically significant association between p27 and cyclin D3 expression was found for the group as a whole. Additionally, when dividing the cases according to the level of expression of cyclin D3 by reactive germinal centers, it was observed that cases with stronger cyclin D3 expression also show higher p27 expression. The relationship between both proteins was also shown at a subcellular level by laser confocal studies, showing that in cases with high expression of both proteins there was a marked colocalization. Additional evidence in favor of p27 sequestration by cyclin D3 was provided by coimmunoprecipitation studies in a Burkitt's cell line (Raji) showing the existence of cyclin D3/p27 complexes and the absence of CDK2/p27 complexes. These results could support the hypothesis that there are cyclin D3/p27 complexes in a subset of aggressive B-cell lymphomas in which p27 lacks the inhibitory activity found when it is bound to cyclin E/CDK2 complexes. This interaction between both proteins could lead to an abnormal nuclear accumulation, detectable by immunohistochemical techniques.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397744

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  hIgD promotes human Burkitt lymphoma Daudi cell proliferation by accelerated G1/S transition via IgD receptor activity.

Authors:  Xing Dai; YuJing Wu; XiaoYi Jia; Yan Chang; HuaXun Wu; Chun Wang; HengShi Chen; WenSheng Chen; Qiong Huang; Wei Wei
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

2.  Accumulation of p27(kip1) is associated with cyclin D3 overexpression in the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma.

Authors:  G Troncone; A Iaccarino; M Russo; E A Palmieri; M Volante; M Papotti; G Viglietto; L Palombini
Journal:  J Clin Pathol       Date:  2006-06-23       Impact factor: 3.411

3.  Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27.

Authors:  M Sánchez-Beato; A I Sáez; I C Navas; P Algara; M Sol Mateo; R Villuendas; F Camacho; A Sánchez-Aguilera; E Sánchez; M A Piris
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

4.  Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions.

Authors:  Sandra S McAllister; Michelle Becker-Hapak; Giuseppe Pintucci; Michele Pagano; Steven F Dowdy
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

Review 5.  Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors.

Authors:  Nawal Bendris; Bénédicte Lemmers; Jean Marie Blanchard
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  p27kip1 expression is inversely related to the grade of gastric MALT lymphoma.

Authors:  Haim Shirin; Vladimir Kravtsov; Mark Shahmurov; Paulina Petchenko; Mona Boaz; Steven F Moss; Yona Avni; Ilana Avinoach
Journal:  Int J Gastrointest Cancer       Date:  2005

7.  Cdk4 deficiency inhibits skin tumor development but does not affect normal keratinocyte proliferation.

Authors:  Marcelo L Rodriguez-Puebla; Paula L Miliani de Marval; Margaret LaCava; David S Moons; Hiroaki Kiyokawa; Claudio J Conti
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  p27Kip1 modulates cell migration through the regulation of RhoA activation.

Authors:  Arnaud Besson; Mark Gurian-West; Anja Schmidt; Alan Hall; James M Roberts
Journal:  Genes Dev       Date:  2004-04-12       Impact factor: 11.361

9.  Expression of cyclin-dependent kinase inhibitor p27(Kip1) in AIDS-related diffuse large-cell lymphomas is associated with Epstein-Barr virus-encoded latent membrane protein 1.

Authors:  Annunziata Gloghini; Gianluca Gaidano; Luigi M Larocca; Francesco Pierconti; Antonella Cingolani; Luigino Dal Maso; Daniela Capello; Silvia Franceschi; Umberto Tirelli; Massimo Libra; Huifeng Niu; Riccardo Dalla-Favera; Antonino Carbone
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

10.  p27 Kip1 protein expression in Hashimoto's thyroiditis.

Authors:  G Troncone; A Iaccarino; A Caleo; D Bifano; G Pettinato; L Palombini
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.